Endocarditis-associated rapidly progressive glomerulonephritis mimicking vasculitis: a diagnostic and treatment challenge

Infective endocarditis (IE)-associated rapidly progressive glomerulonephritis (RPGN) is rarely reported. Sporadic case reports have noted the diagnostic and therapeutic challenge in IE-associated glomerulonephritis because it may masquerade as idiopathic vasculitis. Patients with clinical diagnosis...

Full description

Saved in:
Bibliographic Details
Published inAnnals of medicine (Helsinki) Vol. 54; no. 1; pp. 754 - 763
Main Authors Ai, Sanxi, Liu, Jianzhou, Ma, Guotao, Ye, Wenling, Hu, Rongrong, Zhang, Shangzhu, Fan, Xiaohong, Liu, Bingyan, Miao, Qi, Qin, Yan, Li, Xuemei
Format Journal Article
LanguageEnglish
Published England Taylor & Francis 31.12.2022
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Infective endocarditis (IE)-associated rapidly progressive glomerulonephritis (RPGN) is rarely reported. Sporadic case reports have noted the diagnostic and therapeutic challenge in IE-associated glomerulonephritis because it may masquerade as idiopathic vasculitis. Patients with clinical diagnosis of IE-related RPGN in a tertiary hospital in China between January 2004 and May 2021 were identified and retrospectively reviewed. Twenty-four patients with IE-associated RPGN were identified. All patients presented with fever and multiorgan system involvement on top of heart and kidneys, spleen (79%, 19/24), skin (63%, 15/24), lung (33%, 8/24) and nervous system (17%, 4/24). Six of the 24 patients (25%) were initially suspected to have ANCA-associated or IgA vasculitis. Forty-five percent of patients are seropositive for ANCA. Renal histology showed mesangial and/or endocapillary hypercellularity with extensive crescents in most patients. C3-dominant deposition was the predominant pattern on immunofluorescence and pauci-immune necrotising crescentic glomerulonephritis was observed in one case. All patients received antibiotics with or without surgery. Six patients received immunosuppressive therapy before antibiotics due to misdiagnosis and seven patients received immunosuppressive therapy after antibiotics due to persistence of renal failure. Three of the 24 patients died due to severe infection. All the surviving patients had partial or complete recovery of renal function. IE-associated RPGN is rare and the differential diagnosis from idiopathic vasculitis can be challenging due to overlaps in clinical manifestations, ANCA positivity and absence of typical presentations of IE. The prognosis is generally good if antibiotics and surgery are not delayed. The decision on introducing immunoruppressive treatment should be made carefully on a case by case basis when kidney function does not improve appropriately after proper anti-infective therapy. Key messages Infective endocarditis associated RPGN is rare and differentiating it from idiopathic vasculitis can be challenging due to overlap in clinical manifestations, ANCA positivity and occasional absence of typical manifestations of infective endocarditis. Kidney function usually responds to antibiotic therapy alone. Immunosuppressive therapy may be beneficial in carefully selected patients whose kidney function does not improve with antibiotics alone.
AbstractList Background Infective endocarditis (IE)-associated rapidly progressive glomerulonephritis (RPGN) is rarely reported. Sporadic case reports have noted the diagnostic and therapeutic challenge in IE-associated glomerulonephritis because it may masquerade as idiopathic vasculitis.Methods Patients with clinical diagnosis of IE-related RPGN in a tertiary hospital in China between January 2004 and May 2021 were identified and retrospectively reviewed.Results Twenty-four patients with IE-associated RPGN were identified. All patients presented with fever and multiorgan system involvement on top of heart and kidneys, spleen (79%, 19/24), skin (63%, 15/24), lung (33%, 8/24) and nervous system (17%, 4/24). Six of the 24 patients (25%) were initially suspected to have ANCA-associated or IgA vasculitis. Forty-five percent of patients are seropositive for ANCA. Renal histology showed mesangial and/or endocapillary hypercellularity with extensive crescents in most patients. C3-dominant deposition was the predominant pattern on immunofluorescence and pauci-immune necrotising crescentic glomerulonephritis was observed in one case. All patients received antibiotics with or without surgery. Six patients received immunosuppressive therapy before antibiotics due to misdiagnosis and seven patients received immunosuppressive therapy after antibiotics due to persistence of renal failure. Three of the 24 patients died due to severe infection. All the surviving patients had partial or complete recovery of renal function.Conclusion IE-associated RPGN is rare and the differential diagnosis from idiopathic vasculitis can be challenging due to overlaps in clinical manifestations, ANCA positivity and absence of typical presentations of IE. The prognosis is generally good if antibiotics and surgery are not delayed. The decision on introducing immunoruppressive treatment should be made carefully on a case by case basis when kidney function does not improve appropriately after proper anti-infective therapy.Key messagesInfective endocarditis associated RPGN is rare and differentiating it from idiopathic vasculitis can be challenging due to overlap in clinical manifestations, ANCA positivity and occasional absence of typical manifestations of infective endocarditis.Kidney function usually responds to antibiotic therapy alone.Immunosuppressive therapy may be beneficial in carefully selected patients whose kidney function does not improve with antibiotics alone.
Infective endocarditis (IE)-associated rapidly progressive glomerulonephritis (RPGN) is rarely reported. Sporadic case reports have noted the diagnostic and therapeutic challenge in IE-associated glomerulonephritis because it may masquerade as idiopathic vasculitis.BACKGROUNDInfective endocarditis (IE)-associated rapidly progressive glomerulonephritis (RPGN) is rarely reported. Sporadic case reports have noted the diagnostic and therapeutic challenge in IE-associated glomerulonephritis because it may masquerade as idiopathic vasculitis.Patients with clinical diagnosis of IE-related RPGN in a tertiary hospital in China between January 2004 and May 2021 were identified and retrospectively reviewed.METHODSPatients with clinical diagnosis of IE-related RPGN in a tertiary hospital in China between January 2004 and May 2021 were identified and retrospectively reviewed.Twenty-four patients with IE-associated RPGN were identified. All patients presented with fever and multiorgan system involvement on top of heart and kidneys, spleen (79%, 19/24), skin (63%, 15/24), lung (33%, 8/24) and nervous system (17%, 4/24). Six of the 24 patients (25%) were initially suspected to have ANCA-associated or IgA vasculitis. Forty-five percent of patients are seropositive for ANCA. Renal histology showed mesangial and/or endocapillary hypercellularity with extensive crescents in most patients. C3-dominant deposition was the predominant pattern on immunofluorescence and pauci-immune necrotising crescentic glomerulonephritis was observed in one case. All patients received antibiotics with or without surgery. Six patients received immunosuppressive therapy before antibiotics due to misdiagnosis and seven patients received immunosuppressive therapy after antibiotics due to persistence of renal failure. Three of the 24 patients died due to severe infection. All the surviving patients had partial or complete recovery of renal function.RESULTSTwenty-four patients with IE-associated RPGN were identified. All patients presented with fever and multiorgan system involvement on top of heart and kidneys, spleen (79%, 19/24), skin (63%, 15/24), lung (33%, 8/24) and nervous system (17%, 4/24). Six of the 24 patients (25%) were initially suspected to have ANCA-associated or IgA vasculitis. Forty-five percent of patients are seropositive for ANCA. Renal histology showed mesangial and/or endocapillary hypercellularity with extensive crescents in most patients. C3-dominant deposition was the predominant pattern on immunofluorescence and pauci-immune necrotising crescentic glomerulonephritis was observed in one case. All patients received antibiotics with or without surgery. Six patients received immunosuppressive therapy before antibiotics due to misdiagnosis and seven patients received immunosuppressive therapy after antibiotics due to persistence of renal failure. Three of the 24 patients died due to severe infection. All the surviving patients had partial or complete recovery of renal function.IE-associated RPGN is rare and the differential diagnosis from idiopathic vasculitis can be challenging due to overlaps in clinical manifestations, ANCA positivity and absence of typical presentations of IE. The prognosis is generally good if antibiotics and surgery are not delayed. The decision on introducing immunoruppressive treatment should be made carefully on a case by case basis when kidney function does not improve appropriately after proper anti-infective therapy.Key messagesInfective endocarditis associated RPGN is rare and differentiating it from idiopathic vasculitis can be challenging due to overlap in clinical manifestations, ANCA positivity and occasional absence of typical manifestations of infective endocarditis.Kidney function usually responds to antibiotic therapy alone.Immunosuppressive therapy may be beneficial in carefully selected patients whose kidney function does not improve with antibiotics alone.CONCLUSIONIE-associated RPGN is rare and the differential diagnosis from idiopathic vasculitis can be challenging due to overlaps in clinical manifestations, ANCA positivity and absence of typical presentations of IE. The prognosis is generally good if antibiotics and surgery are not delayed. The decision on introducing immunoruppressive treatment should be made carefully on a case by case basis when kidney function does not improve appropriately after proper anti-infective therapy.Key messagesInfective endocarditis associated RPGN is rare and differentiating it from idiopathic vasculitis can be challenging due to overlap in clinical manifestations, ANCA positivity and occasional absence of typical manifestations of infective endocarditis.Kidney function usually responds to antibiotic therapy alone.Immunosuppressive therapy may be beneficial in carefully selected patients whose kidney function does not improve with antibiotics alone.
Infective endocarditis (IE)-associated rapidly progressive glomerulonephritis (RPGN) is rarely reported. Sporadic case reports have noted the diagnostic and therapeutic challenge in IE-associated glomerulonephritis because it may masquerade as idiopathic vasculitis. Patients with clinical diagnosis of IE-related RPGN in a tertiary hospital in China between January 2004 and May 2021 were identified and retrospectively reviewed. Twenty-four patients with IE-associated RPGN were identified. All patients presented with fever and multiorgan system involvement on top of heart and kidneys, spleen (79%, 19/24), skin (63%, 15/24), lung (33%, 8/24) and nervous system (17%, 4/24). Six of the 24 patients (25%) were initially suspected to have ANCA-associated or IgA vasculitis. Forty-five percent of patients are seropositive for ANCA. Renal histology showed mesangial and/or endocapillary hypercellularity with extensive crescents in most patients. C3-dominant deposition was the predominant pattern on immunofluorescence and pauci-immune necrotising crescentic glomerulonephritis was observed in one case. All patients received antibiotics with or without surgery. Six patients received immunosuppressive therapy before antibiotics due to misdiagnosis and seven patients received immunosuppressive therapy after antibiotics due to persistence of renal failure. Three of the 24 patients died due to severe infection. All the surviving patients had partial or complete recovery of renal function. IE-associated RPGN is rare and the differential diagnosis from idiopathic vasculitis can be challenging due to overlaps in clinical manifestations, ANCA positivity and absence of typical presentations of IE. The prognosis is generally good if antibiotics and surgery are not delayed. The decision on introducing immunoruppressive treatment should be made carefully on a case by case basis when kidney function does not improve appropriately after proper anti-infective therapy.Key messagesInfective endocarditis associated RPGN is rare and differentiating it from idiopathic vasculitis can be challenging due to overlap in clinical manifestations, ANCA positivity and occasional absence of typical manifestations of infective endocarditis.Kidney function usually responds to antibiotic therapy alone.Immunosuppressive therapy may be beneficial in carefully selected patients whose kidney function does not improve with antibiotics alone.
Infective endocarditis (IE)-associated rapidly progressive glomerulonephritis (RPGN) is rarely reported. Sporadic case reports have noted the diagnostic and therapeutic challenge in IE-associated glomerulonephritis because it may masquerade as idiopathic vasculitis. Patients with clinical diagnosis of IE-related RPGN in a tertiary hospital in China between January 2004 and May 2021 were identified and retrospectively reviewed. Twenty-four patients with IE-associated RPGN were identified. All patients presented with fever and multiorgan system involvement on top of heart and kidneys, spleen (79%, 19/24), skin (63%, 15/24), lung (33%, 8/24) and nervous system (17%, 4/24). Six of the 24 patients (25%) were initially suspected to have ANCA-associated or IgA vasculitis. Forty-five percent of patients are seropositive for ANCA. Renal histology showed mesangial and/or endocapillary hypercellularity with extensive crescents in most patients. C3-dominant deposition was the predominant pattern on immunofluorescence and pauci-immune necrotising crescentic glomerulonephritis was observed in one case. All patients received antibiotics with or without surgery. Six patients received immunosuppressive therapy before antibiotics due to misdiagnosis and seven patients received immunosuppressive therapy after antibiotics due to persistence of renal failure. Three of the 24 patients died due to severe infection. All the surviving patients had partial or complete recovery of renal function. IE-associated RPGN is rare and the differential diagnosis from idiopathic vasculitis can be challenging due to overlaps in clinical manifestations, ANCA positivity and absence of typical presentations of IE. The prognosis is generally good if antibiotics and surgery are not delayed. The decision on introducing immunoruppressive treatment should be made carefully on a case by case basis when kidney function does not improve appropriately after proper anti-infective therapy. Key messages Infective endocarditis associated RPGN is rare and differentiating it from idiopathic vasculitis can be challenging due to overlap in clinical manifestations, ANCA positivity and occasional absence of typical manifestations of infective endocarditis. Kidney function usually responds to antibiotic therapy alone. Immunosuppressive therapy may be beneficial in carefully selected patients whose kidney function does not improve with antibiotics alone.
Author Liu, Bingyan
Qin, Yan
Liu, Jianzhou
Ma, Guotao
Zhang, Shangzhu
Fan, Xiaohong
Miao, Qi
Ye, Wenling
Ai, Sanxi
Hu, Rongrong
Li, Xuemei
Author_xml – sequence: 1
  givenname: Sanxi
  surname: Ai
  fullname: Ai, Sanxi
  organization: Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 2
  givenname: Jianzhou
  surname: Liu
  fullname: Liu, Jianzhou
  organization: Department of Cardiac Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 3
  givenname: Guotao
  surname: Ma
  fullname: Ma, Guotao
  organization: Department of Cardiac Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 4
  givenname: Wenling
  surname: Ye
  fullname: Ye, Wenling
  organization: Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 5
  givenname: Rongrong
  surname: Hu
  fullname: Hu, Rongrong
  organization: Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 6
  givenname: Shangzhu
  surname: Zhang
  fullname: Zhang, Shangzhu
  organization: Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 7
  givenname: Xiaohong
  surname: Fan
  fullname: Fan, Xiaohong
  organization: Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 8
  givenname: Bingyan
  surname: Liu
  fullname: Liu, Bingyan
  organization: Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 9
  givenname: Qi
  surname: Miao
  fullname: Miao, Qi
  organization: Department of Cardiac Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 10
  givenname: Yan
  surname: Qin
  fullname: Qin, Yan
  organization: Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
– sequence: 11
  givenname: Xuemei
  surname: Li
  fullname: Li, Xuemei
  organization: Department of Nephrology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35243934$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAQjVAR3RZ-AihHLil27CQOSAhUFahUiQucrYk9ybo49mJ7F-2_x2F3EeUAF1sav48Zz7sozpx3WBTPKbmiRJBXpBMNEz25qkld54O3tRCPihVlbVPVpCVnxWrBVAvovLiI8Z4QUneUPCnOWVNz1jO-KvY3TnsFQZtkYgUxemUgoS4DbIy2-3IT_BQwRrPDcrJ-xrC1uZPNOiyMcjazUd-Mm8odRLW1S_F1CaU2MDkfk1ElOF2mgJBmdKlUa7AW3YRPi8cj2IjPjvdl8fXDzZfrT9Xd54-31-_vKtUwnirdsoF3amB6oIxq3tTjMBDRDJx2facEowMBngfWqLQexdgS3TVaUcprxXnLLovbg672cC83wcwQ9tKDkb8KPkwSQu7TolSsb9RAEcem50LwHhBV_lgchxHajmattwetzXaYUas8UAD7QPThizNrOfmdzDtgXb808_IoEPz3LcYkZxMVWgsO_TbKumUt5Xl7IkNf_On12-S0uwx4cwCo4GMMOEplEiTjF2tjJSVySYo8JUUuSZHHpGR28xf7ZPA_3rsDz7jRhxl--GC1TLC3PowBnDJRsn9L_AQru9lx
CitedBy_id crossref_primary_10_1002_ccr3_9054
crossref_primary_10_2215_CJN_0000000000000503
crossref_primary_10_7759_cureus_63601
crossref_primary_10_1055_a_1949_8509
crossref_primary_10_3892_etm_2024_12504
crossref_primary_10_1016_j_amjmed_2022_06_015
crossref_primary_10_1080_17434440_2022_2151360
Cites_doi 10.1016/j.autrev.2014.10.020
10.1186/1471-2369-13-174
10.1097/MD.0000000000021358
10.1038/s41581-019-0178-8
10.1007/s004670000550
10.1007/s10067-005-0176-z
10.2215/CJN.02500317
10.1177/0300060520963990
10.1080/07853890.2020.1778778
10.3899/jrheum.130150
10.1016/j.amjmed.2014.10.028
10.1371/journal.pone.0089777
10.1002/art.38389
10.1086/313753
10.1097/MD.0000000000002564
10.1016/S0140-6736(06)69114-9
10.1038/ki.2014.424
10.1086/653675
10.5414/CN110202
10.1186/s12882-020-1694-2
10.1086/514734
10.1161/CIRCULATIONAHA.119.040228
10.2169/internalmedicine.5319-20
10.1007/s10067-010-1424-4
10.1053/j.ajkd.2011.06.032
10.21037/jtd.2019.10.45
10.1093/ndt/13.8.2142
ContentType Journal Article
Copyright 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022
2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022 The Author(s)
Copyright_xml – notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022
– notice: 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group 2022 The Author(s)
DBID 0YH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1080/07853890.2022.2046288
DatabaseName Taylor & Francis Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 0YH
  name: Taylor & Francis Open Access
  url: https://www.tandfonline.com
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate S. Ai et al
EISSN 1365-2060
EndPage 763
ExternalDocumentID oai_doaj_org_article_c395cb1eef5948849aeec462efbfa671
PMC8903796
35243934
10_1080_07853890_2022_2046288
2046288
Genre Research Article
Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
00X
03L
0YH
23M
36B
4.4
5GY
5RE
AALUX
ABLKL
ABUPF
ACENM
ACGEJ
ACGFS
ADCVX
ADRBQ
ADXPE
AENEX
AEOZL
AFKVX
AGYJP
AIJEM
AJWEG
ALMA_UNASSIGNED_HOLDINGS
BABNJ
BLEHA
BOHLJ
CCCUG
CS3
DKSSO
EBD
EBS
EMB
EMOBN
F5P
GROUPED_DOAJ
H13
HZ~
KRBQP
KSSTO
KWAYT
KYCEM
LJTGL
M4Z
O9-
OK1
P2P
RPM
SV3
TDBHL
TFDNU
TFL
TFW
V1S
WH7
~1N
AAFWJ
AAYXX
CITATION
.55
.GJ
34G
39C
3O-
53G
5VS
AALIY
AAORF
AAPXX
ABWCV
ABZEW
ADFZZ
AFFNX
AFLEI
AJVHN
AWYRJ
BRMBE
CAG
CGR
COF
CUY
CVF
CYYVM
CZDIS
DRXRE
DWTOO
ECM
EIF
EJD
JENTW
M44
NPM
NUSFT
OVD
QQXMO
TEORI
X7M
ZGI
ZXP
7X8
5PM
ID FETCH-LOGICAL-c534t-d63b47cb3db131d452fbb085b41797c831b0a4206decddf8f60d75dc1142c4463
IEDL.DBID DOA
ISSN 0785-3890
1365-2060
IngestDate Wed Aug 27 01:29:48 EDT 2025
Thu Aug 21 14:21:56 EDT 2025
Thu Jul 10 23:11:32 EDT 2025
Thu Jan 02 22:53:55 EST 2025
Thu Apr 24 23:07:40 EDT 2025
Tue Jul 01 04:55:18 EDT 2025
Wed Dec 25 09:05:37 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords immunosuppressive therapy
Infective endocarditis
RPGN
vasculitis
Language English
License open-access: http://creativecommons.org/licenses/by/4.0/: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c534t-d63b47cb3db131d452fbb085b41797c831b0a4206decddf8f60d75dc1142c4463
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Supplemental data for this article can be accessed here.
OpenAccessLink https://doaj.org/article/c395cb1eef5948849aeec462efbfa671
PMID 35243934
PQID 2636140608
PQPubID 23479
PageCount 10
ParticipantIDs informaworld_taylorfrancis_310_1080_07853890_2022_2046288
crossref_citationtrail_10_1080_07853890_2022_2046288
crossref_primary_10_1080_07853890_2022_2046288
pubmed_primary_35243934
proquest_miscellaneous_2636140608
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8903796
doaj_primary_oai_doaj_org_article_c395cb1eef5948849aeec462efbfa671
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-12-31
PublicationDateYYYYMMDD 2022-12-31
PublicationDate_xml – month: 12
  year: 2022
  text: 2022-12-31
  day: 31
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Annals of medicine (Helsinki)
PublicationTitleAlternate Ann Med
PublicationYear 2022
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References e_1_3_3_30_1
Vercellone J (e_1_3_3_14_1) 2018; 2018
Pendergraft WF (e_1_3_3_13_1) 2016
e_1_3_3_18_1
e_1_3_3_17_1
e_1_3_3_19_1
e_1_3_3_16_1
e_1_3_3_15_1
e_1_3_3_10_1
e_1_3_3_12_1
e_1_3_3_11_1
e_1_3_3_7_1
e_1_3_3_6_1
e_1_3_3_9_1
e_1_3_3_8_1
e_1_3_3_29_1
e_1_3_3_28_1
e_1_3_3_25_1
e_1_3_3_24_1
e_1_3_3_27_1
e_1_3_3_26_1
e_1_3_3_3_1
e_1_3_3_21_1
e_1_3_3_2_1
e_1_3_3_20_1
e_1_3_3_5_1
e_1_3_3_23_1
e_1_3_3_4_1
e_1_3_3_22_1
References_xml – ident: e_1_3_3_16_1
  doi: 10.1016/j.autrev.2014.10.020
– ident: e_1_3_3_28_1
  doi: 10.1186/1471-2369-13-174
– ident: e_1_3_3_9_1
  doi: 10.1097/MD.0000000000021358
– ident: e_1_3_3_25_1
  doi: 10.1038/s41581-019-0178-8
– ident: e_1_3_3_11_1
  doi: 10.1007/s004670000550
– ident: e_1_3_3_20_1
  doi: 10.1007/s10067-005-0176-z
– ident: e_1_3_3_23_1
  doi: 10.2215/CJN.02500317
– ident: e_1_3_3_7_1
  doi: 10.1177/0300060520963990
– volume: 2018
  start-page: 9607582
  year: 2018
  ident: e_1_3_3_14_1
  article-title: Bartonella endocarditis mimicking crescentic glomerulonephritis with PR3-ANCA positivity
  publication-title: Case Rep Nephrol
– ident: e_1_3_3_2_1
  doi: 10.1080/07853890.2020.1778778
– ident: e_1_3_3_15_1
  doi: 10.3899/jrheum.130150
– ident: e_1_3_3_10_1
  doi: 10.1016/j.amjmed.2014.10.028
– ident: e_1_3_3_4_1
  doi: 10.1371/journal.pone.0089777
– ident: e_1_3_3_3_1
  doi: 10.1002/art.38389
– ident: e_1_3_3_12_1
  doi: 10.1086/313753
– ident: e_1_3_3_5_1
  doi: 10.1097/MD.0000000000002564
– start-page: 1072
  volume-title: Brenner & rector’s the kidney
  year: 2016
  ident: e_1_3_3_13_1
– ident: e_1_3_3_17_1
  doi: 10.1016/S0140-6736(06)69114-9
– ident: e_1_3_3_6_1
  doi: 10.1038/ki.2014.424
– ident: e_1_3_3_21_1
  doi: 10.1086/653675
– ident: e_1_3_3_27_1
  doi: 10.5414/CN110202
– ident: e_1_3_3_8_1
  doi: 10.1186/s12882-020-1694-2
– ident: e_1_3_3_30_1
  doi: 10.1086/514734
– ident: e_1_3_3_22_1
  doi: 10.1161/CIRCULATIONAHA.119.040228
– ident: e_1_3_3_24_1
  doi: 10.2169/internalmedicine.5319-20
– ident: e_1_3_3_18_1
  doi: 10.1007/s10067-010-1424-4
– ident: e_1_3_3_19_1
  doi: 10.1053/j.ajkd.2011.06.032
– ident: e_1_3_3_26_1
  doi: 10.21037/jtd.2019.10.45
– ident: e_1_3_3_29_1
  doi: 10.1093/ndt/13.8.2142
SSID ssj0002710
Score 2.4187944
Snippet Infective endocarditis (IE)-associated rapidly progressive glomerulonephritis (RPGN) is rarely reported. Sporadic case reports have noted the diagnostic and...
Background Infective endocarditis (IE)-associated rapidly progressive glomerulonephritis (RPGN) is rarely reported. Sporadic case reports have noted the...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 754
SubjectTerms Endocarditis - complications
Glomerulonephritis - diagnosis
Glomerulonephritis - drug therapy
Humans
immunosuppressive therapy
Infective endocarditis
Kidney - pathology
Nephrology & Urology
Retrospective Studies
RPGN
vasculitis
Vasculitis - complications
Vasculitis - diagnosis
Vasculitis - drug therapy
SummonAdditionalLinks – databaseName: Taylor & Francis Open Access
  dbid: 0YH
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1La9wwEBZtCqWX0ne3L1To1a1kaSW7t6QkLIX01EB7Enqmhl1v2PUG8u8zY8smG1py6NGPsceeGc8nefQNIZ-iEtIFWRWAVlUhnWaFc8oXHuwfpRSx6tn2T3-oxZn8_ms-VhNuc1kljqHTQBTRf6sxuK3bjhVxXyCrQZjWDEZ3Ja6lwuWV1X3yADIxwyYG7Pdi-hiXuickQJECZcZFPP-6zF566ln8b3GY_g2J3i6ovJGhTp6Qxxla0sPBF56Se7F9Rh6e5p_nz8nVcRsgc4FHdM22sNkuMdCNvWjC8or2tVpYFnsZ6flyvYqb3XLdRjA3StBVs2o8zqzToXwVd36lloahWg_uSuGV0ql0nfqxUcsLcnZy_PPbosidF8BGQnZFUMJJ7Z0Ijgse5LxMzgE4c9ivTPtKcMesLJkK0YeQqqRY0PPgcWGuhwGmeEkOWlDwNaEaIYxNgNoYJMzErVLMJ55U6WrHdZoROb5w4zMtOXbHWBo-spdmOxm0k8l2mpHPk9jFwMtxl8ARWnM6GWm1-x3rzbnJUWq8qOfe8RgTsthUsrYxehCPySWrNJ-R-qYvmK6fVUlDCxQj7lDg4-g4BkIY_8vYNq53W1MqASCJKQbnvBocaVIT8DFARiFnRO-52N5z7B9pmz89TTgoIHSt3vyHzm_JI9wciC3fkYNus4vvAYR17kMfZteE5ijg
  priority: 102
  providerName: Taylor & Francis
Title Endocarditis-associated rapidly progressive glomerulonephritis mimicking vasculitis: a diagnostic and treatment challenge
URI https://www.tandfonline.com/doi/abs/10.1080/07853890.2022.2046288
https://www.ncbi.nlm.nih.gov/pubmed/35243934
https://www.proquest.com/docview/2636140608
https://pubmed.ncbi.nlm.nih.gov/PMC8903796
https://doaj.org/article/c395cb1eef5948849aeec462efbfa671
Volume 54
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZgD4gL4k15VEbiGnBix064AdpVhbScWGk5WX5CpDZdddOV9t8zYydVu0LqhasTK2PPOPPZnvmGkA9BcmG9aApAq7IQVrHCWukKB_oPQvDQJLb98x9ycSG-X9aXe6W-MCYs0wPnifvkeFs7W4YQkVikEa0JwQlZhWijkSl7vAKfN22mxn9wpRIPAfi_ugCXzKbcHWTVhjZsgr1hhZlYmJzZHHilRN5_h7r0XwD0bhzlnmM6e0wejYiSfskjeULuhf4peXA-3pk_I7envQeHBYYwdNeFGdURPN2Yq84vb2kK0cJo2JtAfy_Xq7DZLtd9AC1jD7rqVp3DA3Wao1ax8TM11OcgPfgqNb2nu4h16qb6LM_Jxdnpz2-LYiy4AKrhYii85FYoZ7m3JS-9qKtoLWAyi2XKlGt4aZkRFZM-OO9jEyXzqvYO83Ed7Cv5C3LSg4CvCFWIXEwEsMbAT8bSSMlcLKOsbGtLFWdETBOu3chGjkUxlrqcSEtHPWnUkx71NCMfd92uMh3HsQ5fUZu7l5FNOzWAjenRxvQxG5uRdt8W9JAOU2KufKL5EQHeT4ajYeXidYzpw3p7rSvJARsxyeCdl9mQdmICLAakyMWMqAMTOxjH4ZO--5PYwUEArlr5-n8M_A15iGPJxJZvycmw2YZ3AMIGOyf32a_FPK26eToj-wvvxi9d
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4s3yNBIcA07s2AkSBx6ttrTbUyuVk4lfJdJuttrNgvZv8QuZyUvdCtQD6jWJk0lmPPPZmfmGkNdecmGcyCJAqzISRrHIGGkjC_r3QnCfNWz7k0M5PhZfT9KTLfK7r4XBtEpcQ4eWKKLx1Ti5cTO6T4l7B2EN5mnOYHmXYDEV1ldmXWLlvl__gmXb8sPeF9DxmyTZ3Tn6PI66zgIgAxd15CQ3QlnDnYl57ESaBGMAfBjsx6VsxmPDCpEw6bx1LmRBMqdSZ7Hw1MICisN9r5HrKQR7dAbs23jw_olqGBBQxAhl7KuG_iX2Rjxs2gZcIE39G_S9mMF5LiTu3iG3OyxLP7bGd5ds-eoeuTHp_tbfJ-udykGoBBOsy2VUdIbgHV0UZ6WbrmmTHIZ5uD89PZ3OZ36xms4rD_aFI-isnJUWt_Jpmy-LB9_Tgro2PRCeSkGHdMiVp7bvDPOAHF-JQh6S7QoEfEyoQsxUBICJDCJ0iAspmQ1xkInJTazCiIj-g2vb8aBjO46pjnu61E5PGvWkOz2NyNth2FlLBHLZgE-ozeFi5PFuDswXp7pzC9ryPLUm9j4gbU4m8sJ7C8N9MKGQKh6R_Lwt6LrZxgltzxXNLxHgVW84GnwG_ggqKj9fLXUiOaAyJhlc86g1pEFMAOSAUbkYEbVhYhvvsXmmKn80vOQgAFe5fPIfMr8kN8dHkwN9sHe4_5TcwlMtq-Yzsl0vVv45IMDavGimHCXfr3qO_wFusGZc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSouqLyX8jASHANO7NgJEgegXW0prThQqZxM_CqRdrOrfYD2Z_EPmclL3QrUA-o1iZNvd8aez8nMN4S89JIL40QWAVuVkTCKRcZIG1mwvxeC-6xW2z8-kaNT8eksPdsiv7taGEyrxD10aIQi6rUaJ_fMhS4j7g1ENZimOYPdXYK1VFhembV5lUd-_Qt2bYt3h_tg4ldJMjz4-nEUtY0FAAIXy8hJboSyhjsT89iJNAnGAPcw2I5L2YzHhhUiYdJ561zIgmROpc5i3amF_ROH-94gN1OI9dgtgn0b9Yt_omoBBIQYIcauaOhfsDfCYd014JJm6t-Y7-UEzgsRcbhLbrdUlr5vfO8O2fLVXbJz3H6sv0fWB5WDSAkeuCwXUdH6gXd0XsxKN17TOjcM03B_eno-nk78fDWeVh7cC0fQSTkpLb7Jp026LB58SwvqmuxAeCoFE9I-VZ7arjHMfXJ6LQZ5QLYrAPiIUIWUqQjAEhkE6BAXUjIb4iATk5tYhQER3R-ubSuDjt04xjru1FJbO2m0k27tNCCv-2GzRgfkqgEf0Jr9xSjjXR-Yzs91uypoy_PUmtj7gKo5mcgL7y0M98GEQqp4QPKLvqCX9Vuc0LRc0fwKAC86x9GwZOB3oKLy09VCJ5IDKWOSwTUPG0fqYQIfB4rKxYCoDRfb-B2bZ6ryRy1LDgC4yuXj_8D8nOx82R_qz4cnR3vkFp5pNDWfkO3lfOWfAv9bmmf1jKPk-3VP8T-8l2WF
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endocarditis-associated+rapidly+progressive+glomerulonephritis+mimicking+vasculitis%3A+a+diagnostic+and+treatment+challenge&rft.jtitle=Annals+of+medicine+%28Helsinki%29&rft.au=Ai%2C+Sanxi&rft.au=Liu%2C+Jianzhou&rft.au=Ma%2C+Guotao&rft.au=Ye%2C+Wenling&rft.date=2022-12-31&rft.eissn=1365-2060&rft.volume=54&rft.issue=1&rft.spage=754&rft_id=info:doi/10.1080%2F07853890.2022.2046288&rft_id=info%3Apmid%2F35243934&rft.externalDocID=35243934
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0785-3890&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0785-3890&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0785-3890&client=summon